DLGAP2 and colorectal carcinoma: In addition, 4 of the signals detected when CRC was compared with inflammatory bowel disease patients were suggestive: in the HLA region, in the DLGAP2 gene, downstream of the PTCHD3 gene and upstream of the ATP8B4 gene.